Peritoneal Macrophage and Lymphocyte Cytoplasmic Ca2+: Effects on Peritoneal Immune Defense Mechanisms and Ultrafiltration Capacity in Continuous Ambulatory Peritoneal Dialysis

Greelings W. , Tufveson G. , Brunner F.P. Combined report on regular dialysis and transplantation in Europe, XXI, 1990. Nephrol Dial Transplant 1991; 6(Suppl)4: 5–29.

Mistry C. , Gokal R. Factors affecting ultrafiltration in peritoneal dialysis. Contrib Nephrol 1990; 85: 111–7.

Holmes C.J. CAPD-associated peritonitis: An immunological perspective on causes and intervention. Contrib Nephrol 1990; 86: 73–90.

Shaldon S. , Koch K.M. , Quellhorst E. Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Sac Artif Intern Organs 1984; 30: 193–4.

Lamperi S. , Carozzi S. Interferon-gamma (IFNgamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD). Am J Kidney Dis 1988; 11: 225–30.

Lamperi S. , Carozzi S. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis (CAPD). Nephron 1986; 44: 219–25.

Lamperi S. , Carozzi S. , Nasini M.G. Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD. Trans Am Sac Artif Intern Organs 1986; 32: 35–8.

Krane S.M. , Goldring M.B. Potential role for interleukin1 in fibrosis associated with chronic ambulatory peritoneal dialysis. Blood Purif 1988; 6: 173–7.

Lamperi S. , Carozzi S. Lympho-monokine disorders and ultrafiltration loss in CAPD patients. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, Inc, 1987: 7–12.

Maino V.C. , Green N.M. , Crumpton M.J. The role of calcium ions in initiating transformation of lymphocytes. Nature 1974; 29: 251–324.

Lichtman A.H. , Segel G.B. , Lichtman M.A. The role of calcium in lymphocyte proliferation: An interpretative review. Blood 1983; 61: 413–22.

Johnson H.M. , Vassallo T. , Torres B. Interleukin-2-mediated events in alpha-interferon are calcium-dependent at more than one site. J Clin Immunol 1985; 134: 967–70.

Onazaki K.T. , Takenawa T. , Homma Y. The mechanism of macrophage activation induced by Ca++ ionofore. Cell Immunol 1983; 75: 242–54.

Tsien R. , Pozzan T. , Rink T. Calcium homeostasis in intact lymphocytes: Cytoplasmic-free calcium monitored with a new intracellularly trapped fluorescent indicator. J Cell Biol 1982; 94: 324–34.

Scully S.P. , Segel G.B. , Lichtman M.A. Relationship of superoxide production to cytoplasmic free calcium in human monocytes. J Clin Invest 1986; 77: 1349–56.

Strickle D. , Daniel R. , Holian A. Cytosolic calcium, calcium fluxes and regulation of alveolar macrophage superoxide anion production. J Cell Physiol 1984; 121: 458–66.

Amento E.P. , Bhalla A.K. , Kurnik J.T. 1 alpha, 25 dihydroxyvitamin D3 induce maturation on the human monocyte cell line U 937 and, in association with a factor from human T-Iymphocytes, augments production of the monokine mononuclear cell factor. J Clin Invest 1984; 73: 731–9.

Bhalla A.K. , Amento E.P. , Clemens T.L. Specific high-affinity receptors for 1,25–dihydroxyvitamin D3 in human peripheral blood mononuclear cells. Presence in monocytes and induced in T-Iymphocytes following activation. J Clin Endocrinol Metab 1983; 57: 1308–13.

Lamperi S. , Carozzi S. , Nasini M.G. Ultrafiltration loss in continuous ambulatory peritoneal dialysis patients. Effects of intraperitoneal therapy with calcium antagonists. In: Avram M.M. , Giordano C. , eds. Ambulatory peritoneal dialysis. New York and London: Plenum Medical, 1990: 48–52.

Carozzi S. , Nasini M.G. , Schelotto C. Ca++ and 1,25(OH)2D3 enhance peritoneal macrophage (PM) antimicrobial functions in CAPD. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, Inc, 1989: 103–10.

Shany S. , Rapaport J. , Zuili I. Metabolism of 25-OH vitamin D3 by peritoneal macrophages from CAPD patients. Kidney Int 1991; 39: 1005–11.

Provvedini D.M. , Tsoukas C.D. , Deftos L.J. Dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221: 1181–6.

Holder B. , Evequoz V. , Trechsel U. Influence of vitamin D3 metabolism on the production of interleukin 1,2 and 3. Immunology 1985; 170: 256–69.

Abe E. , Miyamura C. , Sakagami H. Differentiation of myeloid leukemia cells induced by 1,25dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981; 78: 4990–4.

Levy R. , Klein J. , Rubinek T. Diversity in peritoneal macrophage response of CAPD patients to dihydroxyvitamin D3. Kidney Int 1990; 37: 1310–5.

Tabata T. , Shoji T. , Kikunami K. In vivo effect of 1 alphahydroxyvitamin D3 on interleukin-2 production in hemodialysis patients. Nephron 1988; 50: 295–8.

Carozzi S. , Nasini M.G. , Schelotto C. Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patients. Trans Am Soc Artif Intern Organs 1990; 36: 467–9.

Krane S. , Goldring M.B. Potential role of interleukin-l in fibrosis associated with chronic ambulatory peritoneal dialysis. Blood Purif 1988; 6: 173–7.

Carozzi S. , Nasini M.G. , Cantaluppi A. Peritoneal dialysis solution calcium concentration regulates peritoneal fibroblast proliferation in CAPD. Trans Am Soc Artif Intern Organs 1992; 38: 593–5.

Lamperi S. , Carozzi S. , Nasini M.G. Effect of intraperitoneal verapamil therapy on ultrafiltration (UF) in CAPD patients with peritoneal hypopermeability. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, Inc, 1988: 15–20.